Inflammatory Bowel Diseases

Skip Navigation LinksHome > January 2009 - Volume 15 - Issue 1 > Intestinal barrier dysfunction in inflammatory bowel disease...
Inflammatory Bowel Diseases:
doi: 10.1002/ibd.20539
Basic Science Reviews

Intestinal barrier dysfunction in inflammatory bowel diseases

McGuckin, Michael A. PhD1,*; Eri, Rajaraman PhD1,2; Simms, Lisa A. BSc3,4,5; Florin, Timothy H.J. MD2; Radford‐Smith, Graham DPhil3,4,5

Collapse Box


The etiology of human inflammatory bowel diseases (IBDs) is believed to involve inappropriate host responses to the complex commensal microbial flora in the gut, although an altered commensal flora is not completely excluded. A multifunctional cellular and secreted barrier separates the microbial flora from host tissues. Altered function of this barrier remains a major largely unexplored pathway to IBD. Although there is evidence of barrier dysfunction in IBD, it remains unclear whether this is a primary contributor to disease or a consequence of mucosal inflammation. Recent evidence from animal models demonstrating that genetic defects restricted to the epithelium can initiate intestinal inflammation in the presence of normal underlying immunity has refocused attention on epithelial dysfunction in IBD. We review the components of the secreted and cellular barrier, their regulation, including interactions with underlying innate and adaptive immunity, evidence from animal models of the barrier's role in preventing intestinal inflammation, and evidence of barrier dysfunction in both Crohn's disease and ulcerative colitis.

© Crohn's & Colitis Foundation of America, Inc.

You currently do not have access to this article.

You may need to:

Note: If your society membership provides for full-access to this article, you may need to login on your society’s web site first.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.